Sernova – Patentierte Zelltaschen mit Schutzschild gegen die Immunabwehr ! (Seite 658)
eröffnet am 24.06.15 16:59:24 von
neuester Beitrag 01.06.24 22:27:25 von
neuester Beitrag 01.06.24 22:27:25 von
Beiträge: 8.636
ID: 1.214.676
ID: 1.214.676
Aufrufe heute: 24
Gesamt: 1.085.929
Gesamt: 1.085.929
Aktive User: 0
ISIN: CA81732W1041 · WKN: A0LBCR · Symbol: SVA
0,2435
EUR
+8,46 %
+0,0190 EUR
Letzter Kurs 31.05.24 L&S Exchange
Neuigkeiten
| TitelBeiträge |
|---|
30.05.24 · Shareribs Anzeige |
29.05.24 · wO Chartvergleich |
28.05.24 · Shareribs Anzeige |
28.05.24 · IRW Press |
Werte aus der Branche Gesundheitswesen
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 2,4900 | +185,09 | |
| 1,0500 | +128,31 | |
| 0,9899 | +41,41 | |
| 3,3400 | +17,40 | |
| 2,4700 | +14,88 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,4350 | -18,47 | |
| 5,5100 | -18,97 | |
| 1,5000 | -25,00 | |
| 0,9000 | -53,85 | |
| 0,6002 | -57,27 |
Beitrag zu dieser Diskussion schreiben
Feedback
Piotr
Laboratory
Witkowski
DIABETES/ ISLET Tx
SERNOVA
PANCREATITIS/ ISLET Tx
KIDNEY Tx
TREGS
NEWS
TEAM
TRAINING
GALLERY
MENTORS
New study
in islet transplantation
Sernova Cell Pouch Study
see updates
Allotransplantation for patients with T1DM
OPEN ENROLLMENT
A Safety, Tolerability and Efficacy Study of Sernova Cell Pouch™ for Clinical Islet Transplantation.
Funded by Sernova/JDRF
Home
Brief description
Enroll Here
Dear Patient,
I am writing to let you know about an opportunity to participate in a research study designed for patients with "brittle" form of Type 1 Diabetes.
This study is being conducted by myself, Dr. Piotr Witkowski at the University of Chicago. This research study will assess the safety, tolerability and efficacy of the Sernova Cell Pouch™ that will be implanted under the skin, and transplanted with islets.
You may be eligible for this study if:
you are between the ages of 18-65,
have been diagnosed with Type 1 Diabetes for longer than 5 years,
suffer from sudden and unpredictable drops of blood glucose leading to confusion or passing out despite the best medical treatment of insulin under the guidance of an experienced diabetologist.
If you are interested in learning more about the study, please contact our Research Manager Lindsay Basto, RN, MSN,
Lindsay.Basto@uchospitals.edu or call 773-702-2504 for additional information. You also will be given password to access Brief description of the study. You will be able to print Patient information package there as well.
At any time you can review our enrollment process: at Enroll Here, There are 2 forms to be filled out and emailed to us.
It is important to know that this letter is not to tell you to join the study.
It is your decision, and your participation is voluntary.
Whether you show interest, and participate in the study or not, it will have no effect on your treatment with your doctors. We would also like to let you know that Dr. Witkowski has a relationship with the study sponsor, Sernova Corp since he received financial compensation from the sponsor for designing the protocol of the study in 2016.
Thank you for your interest and consideration,
Piotr Witkowski M.D. Ph.D
Press Release
November 18th, 2020
CONTACT:
Piotr
Witkowski
Laboratory
Transplantation Institute
Clinical Research Center
Islet and Kidney Transplantation
Manager, Lindsay Basto RN MSN
Lindsay.Basto@uchospitals.edu
tel. (773) 702-2504
fax (773) 926-0671
Islet and Cell Processing and Research
Manager, Karolina Golab, PhD
kgolab@surgery.bsd.uchicago.edu
Facebook
Twitter
Polish-American
Transplant Center
Polish-American Transplant Center
Clinical Coordinator
Patrycja Ulijaszyk RN
Patrycja.Ulijaszyk@uchospitals.edu
Transplantation Institute
University of Chicago Medicine
5841 S. Maryland Avenue
MC 5026, J-517
Chicago IL 60637
Laboratory
Witkowski
DIABETES/ ISLET Tx
SERNOVA
PANCREATITIS/ ISLET Tx
KIDNEY Tx
TREGS
NEWS
TEAM
TRAINING
GALLERY
MENTORS
New study
in islet transplantation
Sernova Cell Pouch Study
see updates
Allotransplantation for patients with T1DM
OPEN ENROLLMENT
A Safety, Tolerability and Efficacy Study of Sernova Cell Pouch™ for Clinical Islet Transplantation.
Funded by Sernova/JDRF
Home
Brief description
Enroll Here
Dear Patient,
I am writing to let you know about an opportunity to participate in a research study designed for patients with "brittle" form of Type 1 Diabetes.
This study is being conducted by myself, Dr. Piotr Witkowski at the University of Chicago. This research study will assess the safety, tolerability and efficacy of the Sernova Cell Pouch™ that will be implanted under the skin, and transplanted with islets.
You may be eligible for this study if:
you are between the ages of 18-65,
have been diagnosed with Type 1 Diabetes for longer than 5 years,
suffer from sudden and unpredictable drops of blood glucose leading to confusion or passing out despite the best medical treatment of insulin under the guidance of an experienced diabetologist.
If you are interested in learning more about the study, please contact our Research Manager Lindsay Basto, RN, MSN,
Lindsay.Basto@uchospitals.edu or call 773-702-2504 for additional information. You also will be given password to access Brief description of the study. You will be able to print Patient information package there as well.
At any time you can review our enrollment process: at Enroll Here, There are 2 forms to be filled out and emailed to us.
It is important to know that this letter is not to tell you to join the study.
It is your decision, and your participation is voluntary.
Whether you show interest, and participate in the study or not, it will have no effect on your treatment with your doctors. We would also like to let you know that Dr. Witkowski has a relationship with the study sponsor, Sernova Corp since he received financial compensation from the sponsor for designing the protocol of the study in 2016.
Thank you for your interest and consideration,
Piotr Witkowski M.D. Ph.D
Press Release
November 18th, 2020
CONTACT:
Piotr
Witkowski
Laboratory
Transplantation Institute
Clinical Research Center
Islet and Kidney Transplantation
Manager, Lindsay Basto RN MSN
Lindsay.Basto@uchospitals.edu
tel. (773) 702-2504
fax (773) 926-0671
Islet and Cell Processing and Research
Manager, Karolina Golab, PhD
kgolab@surgery.bsd.uchicago.edu
Polish-American
Transplant Center
Polish-American Transplant Center
Clinical Coordinator
Patrycja Ulijaszyk RN
Patrycja.Ulijaszyk@uchospitals.edu
Transplantation Institute
University of Chicago Medicine
5841 S. Maryland Avenue
MC 5026, J-517
Chicago IL 60637
Genau das meinte ich. Es wurde hier verbreitet, dass es eigentlich nur eine Richtung geben kann. dann steigen hier Leute für 5000€ und mehr bei 2€ ein, weil es ja leicht verdiente Kohle und 2€ Ja nur eine Zwischenstation ist. Dienstag 2,50€, am Mittwoch 5€ und am Ende der Woche vielleicht 10€. Und das ist alles erst der Anfang.......
Zack und nun jammern die ersten Profis bei 1€ rum.
Nun bin ich mal gespannt wie es weitergeht wenn die Optionen gezogen werden können. Auch ich hoffe langfristig auf höhere Kurse, aber kurzfristig ist alles in alle Richtungen drin. Für mich zumindest nicht vorhersehbar.
Zack und nun jammern die ersten Profis bei 1€ rum.
Nun bin ich mal gespannt wie es weitergeht wenn die Optionen gezogen werden können. Auch ich hoffe langfristig auf höhere Kurse, aber kurzfristig ist alles in alle Richtungen drin. Für mich zumindest nicht vorhersehbar.
Antwort auf Beitrag Nr.: 66.526.505 von checkpointuk am 20.01.21 17:05:44Wie erwartet , frage nur bremst es hier oder weiter runter
musste jetzt doch zu 1,01 nachlegen...die 96 wird wohl schwierig werden...
Passt auch so
Passt auch so
wow
wie Übel.......................... Trading Spotlight
...das würde ich jetzt nicht sagen...ich verdopple bei 96
Darauf habe ich heute lange genug gewartet
Darauf habe ich heute lange genug gewartet
zurück auf los
kanadische Aktien
kanadische Aktien
die Messe ist gelesen.....das wars wohl
War doch klar ......geht wieder zurück auf 75 cent ....mein gefühl
Eröffnungsgap in Can geschlossen, dümpelt bei -5% rum.
Kannst auf Finance Yahoo schauen zwecks RT-Kurse
Kannst auf Finance Yahoo schauen zwecks RT-Kurse
Durchsuchen
Sernova – Patentierte Zelltaschen mit Schutzschild gegen die Immunabwehr !
